Mercado Doraverin tablets, Bayer hydrochloric acid logging non-slices... A batch of drugs was approved for sale in China

The official website of the State Drug Administration issued a batch of drug approval documents to be received information, which related to Mercado Doraverin tablets, Bayer hydrochloric acid valdina tablets, Sino-American East-West Gretin metformin tablets (I) ... Doravirine is a once-a-day oral innovative non-nucleoside retrovirase inhibitor developed by Mercado.
the drug can be used as a flexible combination of a single-chip preparation with other antiviral therapies to treat HIV-1 infections, or as a fixed-dose compound preparation in combination with lamivudine (3TC) and tenofovir (TDF).
the drug was first approved by the FDA in August 2018.
hydrochloric acid logging non-tablet hydrochloric acid non-tablet for Bayer and GlaxoSmithKline jointly developed phosphate dylsterase 5 (PDE5) inhibitors, first approved in the European Union in 2003, and then approved in the United States, Japan, Canada and other countries, in 2004 the first time in China approved imports for the treatment of erectile dysfunction of the male penis.
the domestic side, in July this year, Colum Pharmaceuticals hydrochloric acid logging non-tablets were approved for market, becoming the first domestic variety approved for the market of generic drugs.
Sigletin metformin Siglutin metformin is a complementary mechanism of action of the sugar-lowering drug compound preparation, with diet and exercise therapy, for the treatment of metformin single drug blood sugar is still poorly controlled or is receiving a combined treatment of the two type 2 diabetic patients.
the drug was originally developed by Mercadon, which will have global sales of more than $2 billion in 2019.
this year, The East Sunshine Drug's Sigretin metformin tablets won the first domestic imitation.
this time in eastern China and the United States, Sigretin metformin tablets (I) was approved, becoming the second domestic qualified Sigletin metformin manufacturers.
。